Quick Answer
Unicycive Therapeutics, Inc. reported Common Stock Shares Outstanding of 22.11 million shares for the year ending 2025.
- Unicycive Therapeutics, Inc. showed an increase of +94.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Unicycive Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Unicycive Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 159.7%.
- Historical annual values: Fiscal year 2025: 22.11 million shares | Fiscal year 2024: 11.38 million shares | Fiscal year 2023: 34.76 million shares | Fiscal year 2022: 15.23 million shares | Fiscal year 2021: 15.00 million shares | Fiscal year 2020: 8.51 million shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: